Skip to main content

Advertisement

Table 2 Comparison of primary and secondary outcomes between the treatment and control groups

From: Intra-arterial ethanol embolization augments response to TACE for treatment of HCC with portal venous tumor thrombus

Outcome Treatment group Control group P-value
Tumor responseb n = 29 n = 53 0.61
 Complete response 2 (7) 6 (11.3)  
 Partial response 9 (31) 5 (9.4)  
 Stable disease 12 (41.3) 35 (66.1)  
 Progressive disease 6 (20.7) 7 (13.2)  
Portal vein tumor thrombus responseb n = 29 n = 53 < 0.001
 Grade 3 6 (20.7) 1 (1.9)  
 Grade 2 15 (51.7) 6 (11.3)  
 Grade 1 6(20.7) 10 (18.9)  
 Grade 0 2 (6.9) 36 (67.9)  
Overall survival (%) n = 31 n = 57 0.001
 At 3-months 90.3 59.6  
 At 6-months 64.5 29.8  
 At 12-months 41.9 10.6  
  1. Values are depicted as n (%)
  2. bBefore the statistics were performed, two patients died in treatment group and control group, respectively